Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Dario Formica"'
Publikováno v:
Healthcare
Volume 11
Issue 5
Pages: 635
Volume 11
Issue 5
Pages: 635
This real-world analysis was performed on administrative databases to evaluate characteristics, therapies, and related economic burden of glaucoma in Italy. Adults with at least 1 prescription for ophthalmic drops (ATC class S01E: antiglaucoma prepar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::929c008725bd1b4dbc347796a2907b44
Autor:
Valeria Pizzimenti, Dario Formica, Simona Lucchesi, Gianluca Trifirò, A Aiello, Valentina Ientile, Janet Sultana
Publikováno v:
Gazzetta Medica Italiana Archivio per le Scienze Mediche, 179(5), 317-325. Edizioni Minerva Medica
BACKGROUND: In Italy, pharmaceutical market access depends on European Medicines Agency (EMA), Italian national drug agency (AIFA) and regional regulatory procedures (Sicilian Drug Formulary Committee). The regulatory and economic outcomes of the Sic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fd687764e8b6029a43d614d24394d5f
https://doi.org/10.23736/s0393-3660.19.04030-0
https://doi.org/10.23736/s0393-3660.19.04030-0
Autor:
Mariangela Rossi, Giuseppe Traversa, Pasquale Cananzi, Janet Sultana, Maurizio Pastorello, A Aiello, Daniele Ugo Tari, Ylenia Ingrasciotta, Alessandro Chinellato, Dario Formica, Valentina Ientile, Gianluca Trifirò, Salvatore Scondotto, Rosa Gini, Domenico Santoro
Publikováno v:
Pharmacoepidemiology and drug safetyREFERENCES. 30(1)
Purpose Erythropoiesis-stimulating agents (ESAs), are used for treating chronic kidney disease (CKD)-related anemia, contributing to CKD costs. The study was aimed at investigating direct healthcare costs of CKD patients treated with ESAs and the pot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::040ae543f335a378e622a39da545a305
https://pubmed.ncbi.nlm.nih.gov/33067914
https://pubmed.ncbi.nlm.nih.gov/33067914